Business
cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance
cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with hemp derived THC beverage line Herbal Oasis today announced our financial results for the full fiscal year ended September 30, 2025.
About this update from Cbdmd, Inc.
[{"type":"text","content":"CHARLOTTE, N.C., Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with hemp derived THC beverage line Herbal Oasis today announced our financial results for the full fiscal year ended September 30, 2025.","length":369,"tagName":"p"},{"type":"image","alt":"cbdMD logo (PRNewsfoto/cbdMD, Inc.)","displaySize":"","headline":null,"caption":"cbdMD logo (PRNewsfoto/cbdMD, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":172,"url":"https://media.zenfs.com/en/prnewswire.com/39be855165955bdcbd347db26f31394c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Are4s7tGw9fhk38euB0v9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTMwMztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/39be855165955bdcbd347db26f31394c","width":400,"height":172}},"href":"https://mma.prnewswire.com/media/2829180/cbdMD_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"For fiscal year 2025, cbdMD delivered its third consecutive year of operational and financial improvement, reflecting disciplined cost management, focused execution, and continued investment in quality and science.","length":214,"tagName":"p"},{"type":"text","content":"The Company reported a loss from operations of $2.1 million, representing a $1.2 million year-over-year improvement from a $3.3 million operating loss in fiscal 2024. As a result of balance-sheet actions completed during the year, including the conversion of Series A preferred equity, net book value improved from under $2.0 million to approximately $7.2 million at year-end. The Company took further steps this week to strengthen its balance sheet and raised an additional $2.25 million in gross proceeds from the sale of Series C Convertible Preferred Stock. Management believes the current capital structure provides flexibility to support growth initiatives and opportunities ahead in 2026.","length":695,"tagName":"p"},{"type":"text","content":""Fiscal 2025 marked an important inflection point for cbdMD as we delivered our third straight year of operating improvement while completing several foundational balance-sheet and compliance milestones," said Ronan Kennedy, CEO and CFO of cbdMD. "We believe our ...